Exclusive Report: Pharma IP Rights At Risk In Asia
This article was originally published in PharmAsia News
Executive Summary
Rockville, Md. (April 9, 2007) PharmAsia News announces the publication of an exclusive report: Pharma IP Rights At Risk In Asia. The report examines the ongoing compulsory license dispute in Thailand, where the government recently issued compulsory licenses for brand name drugs manufactured by Abbott, Merck and Sanofi-Aventis